Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins

被引:286
作者
Gires, O
Kohlhuber, F
Kilger, E
Baumann, M
Kieser, A
Kaiser, C
Zeidler, R
Scheffer, B
Ueffing, M
Hammerschmidt, W
机构
[1] GSF, Natl Res Ctr Environm & Hlth, D-81377 Munich, Germany
[2] Inst Clin Mol Biol & Tumor Genet, D-81377 Munich, Germany
[3] Dept Gene Vectors, D-81377 Munich, Germany
[4] Univ Munich, Dept Otorhinolaryngol, D-81377 Munich, Germany
关键词
B lymphocyte; EBV; JAK3; LMP1; STAT protein;
D O I
10.1093/emboj/18.11.3064
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Latent membrane protein 1 (LMP1) acts like a permanently activated receptor of the tumor necrosis factor (TNF)-receptor superfamily and is absolutely required for B cell immortalization by Epstein-Barr virus. Molecular and biochemical approaches demonstrated that LMP1 usurps cellular signaling pathways resulting in the induction of NF-kappa B and AP-1 via two C-terminal activating regions. We demonstrate here that a third region encompassing a proline rich sequence within the 33 bp repetitive stretch of LMP1's C-terminus is required for the activation of Janus kinase 3 (JAK3). The interaction of LMP1 and JAK3 leads to the enhanced tyrosine auto/transphosphorylation of JAK3 within minutes after crosslinking of a conditional NGF-R:LMP1 chimera and is a prerequisite for the activation of STAT transcription factors. These results reveal a novel activating region in the LMP1 C-terminus and identify the JAK/STAT pathway as a target of this viral integral membrane protein in B cells.
引用
收藏
页码:3064 / 3073
页数:10
相关论文
共 59 条
[1]  
BAICHWAL VR, 1988, ONCOGENE, V2, P461
[2]   JAKs and STATs branch out [J].
Briscoe, J ;
Kohlhuber, F ;
Muller, M .
TRENDS IN CELL BIOLOGY, 1996, 6 (09) :336-340
[3]   Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells [J].
Catlett-Falcone, R ;
Landowski, TH ;
Oshiro, MM ;
Turkson, J ;
Levitzki, A ;
Savino, R ;
Ciliberto, G ;
Moscinski, L ;
Fernández-Luna, JL ;
Nuñez, G ;
Dalton, WS ;
Jove, R .
IMMUNITY, 1999, 10 (01) :105-115
[4]   EPSTEIN-BARR-VIRUS NUCLEAR PROTEIN-2 MUTATIONS DEFINE ESSENTIAL DOMAINS FOR TRANSFORMATION AND TRANSACTIVATION [J].
COHEN, JI ;
WANG, F ;
KIEFF, E .
JOURNAL OF VIROLOGY, 1991, 65 (05) :2545-2554
[5]   STATs and gene regulation [J].
Darnell, JE .
SCIENCE, 1997, 277 (5332) :1630-1635
[6]   Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells [J].
Delecluse, HJ ;
Hilsendegen, T ;
Pich, D ;
Zeidler, R ;
Hammerschmidt, W .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (14) :8245-8250
[7]  
DELECLUSE HJ, 1999, IN PRESS P NATL ACAD
[8]  
Devergne O, 1996, MOL CELL BIOL, V16, P7098
[9]   Epstein-Barr virus: LMP1 masquerades as an active receptor [J].
Eliopoulos, AG ;
Rickinson, AB .
CURRENT BIOLOGY, 1998, 8 (06) :R196-R198
[10]   Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappa B pathway involving TNF receptor-associated factors [J].
Eliopoulos, AG ;
Stack, M ;
Dawson, CW ;
Kaye, KM ;
Hodgkin, L ;
Sihota, S ;
Rowe, M ;
Young, LS .
ONCOGENE, 1997, 14 (24) :2899-2916